Spectrum Pharmaceutecals Inc (SPPI)

[Ville7]

MD Anderson - clinical trial exon-20 poziotinib - analysis ( (c) Ville) from inspire.com patient postings and SPPI CCs:

Number of patient - Username in inspire.com / mutation / posted personal results by patient

1. ??? - first compassionate use patient / exon-20 HER2 / stable 9 months now

2. Anne121259 - second compassionate use patient / exon-20 EGFR / mixed (better in bone and pain, but growing lung tumor)

3. Lili123 - NCT03066206 trial / exon-20 EGFR / patient can breath again after 3 weeks

4. 20165 - NCT03066206 trial, start: Jun 26 / exon-20 ??? / shrinking in brain, mets, lung

5. Gardengal1565 - NCT03066206 trial / exon-20 EGFR / pain reduced, needs rarely pain meds now

6. janet129 - NCT03066206 trial start: 8/18/17 / exon-20 EGFR / no results feedback yet